Metformin Hydrochloride/Sitagliptin Hydrochloride

盐酸二甲双胍/盐酸西格列汀

Report date: 2024/03/07 11:53:38

Base Information

Drug NameMetformin Hydrochloride/Sitagliptin Hydrochloride

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionProtein kinase AMP-activated non-catalytic subunit beta 1 activatorsDipeptidyl peptidase IV inhibitors

TargetsProtein kinase AMP-activated non-catalytic subunit beta 1Dipeptidyl peptidase IV

Therapy Area/IndicationsN/A

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryEU

Original Approved Date2019/12/10

Country/TerritoryEU

Global Highest StatusApproved

Highest Status in ChinaN/A

Originator CompaniesSandoz Bv

China Registration ClassN/A

Active CompaniesSandoz Bv

Inactive CompaniesN/A

Active IndicationsN/A

Inactive IndicationsN/A

ATC CodeA10BD07